Capital expenditure increased 161.9%
Capital expenditure changed +161.9% from the comparable as-filed period.
$247.0M→$647.0M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →GEV financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Inventory / revenue moved 256 bp higher
Inventory / revenue changed +256 basis points from the comparable as-filed period.
100.63%→103.19%2 prior comparisons
Free-cash-flow margin moved 3544 bp higher
Free-cash-flow margin changed +3544 basis points from the comparable as-filed period.
7.35%→42.79%2 prior comparisons
Working capital / assets moved 1436 bp lower
Working capital / assets changed -1436 basis points from the comparable as-filed period.
1.85%→-12.51%3 prior comparisons
Operating cash-flow margin moved 3808 bp higher
Operating cash-flow margin changed +3808 basis points from the comparable as-filed period.
9.83%→47.91%2 prior comparisons
Cost of revenue increased 18.2%
Cost of revenue changed +18.2% from the comparable as-filed period.
$8.1B→$9.5B2 prior comparisons
Operating cash flow / net income increased 116.4%
Operating cash flow / net income changed +116.4% from the comparable as-filed period.
2.17→4.691 prior comparisons
Research & development increased 15.5%
Research & development changed +15.5% from the comparable as-filed period.
$310.0M→$358.0M2 prior comparisons
Working capital changed across a sign change
Working capital changed -1172.2% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
$1.0B→-$10.8B3 prior comparisons
Current ratio decreased 19.6%
Current ratio changed -19.6% from the comparable as-filed period.
1.03→0.833 prior comparisons
Selling, general & administrative increased 10.9%
Selling, general & administrative changed +10.9% from the comparable as-filed period.
$1.2B→$1.4B2 prior comparisons
R&D / revenue moved 28 bp lower
R&D / revenue changed -28 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
3.11%→2.83%2 prior comparisons
Capital expenditure increased 123.1%
Capital expenditure changed +123.1% from the comparable as-filed period.
$173.0M→$386.0M3 prior comparisons
Gross profit increased 27.8%
Gross profit changed +27.8% from the comparable as-filed period.
$1.8B→$2.4B2 prior comparisons
Cost of revenue increased 20.3%
Cost of revenue changed +20.3% from the comparable as-filed period.
$7.3B→$8.7B2 prior comparisons
Gross margin moved 99 bp higher
Gross margin changed +99 basis points from the comparable as-filed period.
20.26%→21.25%2 prior comparisons
Working capital / assets moved 1218 bp lower
Working capital / assets changed -1218 basis points from the comparable as-filed period.
1.79%→-10.39%3 prior comparisons
Free-cash-flow margin moved 4385 bp higher
Free-cash-flow margin changed +4385 basis points from the comparable as-filed period.
2.13%→45.98%2 prior comparisons
Operating cash-flow margin moved 4543 bp higher
Operating cash-flow margin changed +4543 basis points from the comparable as-filed period.
4.03%→49.46%2 prior comparisons
Capex / revenue moved 158 bp higher
Capex / revenue changed +158 basis points from the comparable as-filed period.
1.90%→3.48%2 prior comparisons
Shares outstanding decreased 2.2%
Shares outstanding changed -2.2% from the comparable as-filed period. The change ranks at the 80th percentile of 5 prior comparable changes.
272,223,940→266,333,5815 prior comparisons
Research & development increased 18.4%
Research & development changed +18.4% from the comparable as-filed period.
$282.0M→$334.0M2 prior comparisons
Working capital changed across a sign change
Working capital changed -985.8% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
$948.0M→-$8.4B3 prior comparisons
Current ratio decreased 17.4%
Current ratio changed -17.4% from the comparable as-filed period.
1.03→0.853 prior comparisons
Selling, general & administrative increased 15.8%
Selling, general & administrative changed +15.8% from the comparable as-filed period.
$1.2B→$1.4B2 prior comparisons
Operating cash flow / net income changed across a low base
Operating cash flow / net income changed +1051.5% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base.
0.71→8.221 prior comparisons
R&D / revenue moved 9 bp lower
R&D / revenue changed -9 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
3.10%→3.01%2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.